Verseon is engaged in the development of novel drug candidates using physics and AI-driven precision engineering, focusing on treatments for major human diseases.

Verseon

Verseon | 1,360 followers on LinkedIn. Game-Changing Technology, 
Life-Changing Medicines | Verseon delivers pharmaceutical solutions using proprietary, computer-driven drug discovery platform technology. Through scientific advancements in physics- and chemistry-based modeling, Verseon’s gol is to address the cycle of slow and derivative pharmaceutical developments to create truly novel molecular entities. We innovate beyond the bounds of the known and design, test, and synthesize never-been-seen molecules that may soon become life-changing drugs.

Head of Machine Learning Applications at Verseon

Edward Ratner

Anirban Datta

Kevin Short

Small Molecule Drug Discovery • Translational Research • Clinical Development • Biotech R&D • Strategic Guidance • Managing People • Building Drug…

David Kita

We're exploring uncharted chemical space to find drugs that dramatically improve disease treatment. Newsweek just published an article describing how we combine our fundamental quantum physics advances and innovative AI to systematically create medical breakthroughs. We’re finding answers for major human diseases that have long stood as formidable challenges: first-in-class treatments to safely prevent strokes and heart attacks, diabetic end-organ damage, and more. #Verseon #AIinMedicine #DrugDiscovery #HealthcareInnovation #Newsweek #MedicalBreakthroughs #Pharmaceuticals ➡️ https://lnkd.in/gmzvjbCt

Verseon platform featured as THE drug discovery solution in just released Forbes article on the future of medicine: https://lnkd.in/g9DFZKbA The way this article lays out the challenges and solutions to finding the life-changing medicines of the future makes it a worthwhile read. #AI #Health #Medicine #Pharmaceuticals

At Verseon, we relentlessly pursue technological advancements in-house whenever other current tools are inadequate to the tasks at hand. Our team’s most recent peer-reviewed paper describes our novel technique to combine AI models that offers a 150% improvement over the current state-of-the-art method. https://lnkd.in/guajFfNe #AI #DrugDiscovery #ensembling #innovation #pharmaceuticals #Verseon

Verseon's CEO Adityo Prakash recently shared some thought-provoking observations about the future of biotechnology and its implications for humanity in an article appearing on Homeland Security Today. #biotechnology #HomelandSecurity #medicine #pharmaceuticals #Verseon

Verseon is proud to introduce VersAI™, the world's most accurate AI for handling the small, sparse datasets typical of most real-world scenarios. Lack of big data is a major problem in small-molecule drug discovery, so we continue to develop our own tools, which now show utility far outside drug discovery alone. One of the biggest challenges facing most companies using AI today is getting their hands on enough high-quality training data for their specific applications. For all such scenarios, VersAI™ shines. As our peer-reviewed results show, VersAI™ yields up to 35% more accurate predictions than current state-of-the-art Google AutoML on benchmark datasets. https://lnkd.in/gtsaTf98 #AI #BigData #DrugDiscovery #GoogleAutoML #pharmaceuticals #smalldata #VersAI #Verseon

Inside Precision Medicine: How Verseon’s new tech unlocks a seemingly infinite chemical space inaccessible to the rest of the pharmaceutical industry. https://lnkd.in/gzjkexpj #AI #breakthrough #DrugDiscovery #pharmaceuticals #Verseon

Next Big Future’s Brian Wang reflects on the failures of current drug-discovery AI and references Verseon's approach as the solution. https://lnkd.in/g8_APixj #AI #DrugDiscovery #NextBigFuture #pharmaceuticals #Verseon

Adityo Prakash

Verseon's CEO Adityo Prakash speaks with Dan Turchin on the “AI and the Future of Work” podcast. #health #disease #aging #AI #quantum #physics #populationgrowth #sustainability

Verseon CEO Adityo Prakash discusses the role of AI in drug discovery and healthcare with Health Connective host Michael Roberts. https://lnkd.in/gc9aBftx #AI #healthcare #pharmaceuticals #HealthConnective #Verseon

Verseon CEO Adityo Prakash: "AI will make healthcare delivery much more efficient. But a major factor that determines cost... is human greed. Unfortunately, AI can’t help us there." https://lnkd.in/gnCUEMcG #Verseon #ABC #AI #healthcare #pharmaceuticals

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 2:48 PM	90a1d6fa
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 2:48 PM	d6c2ce06
crunchbase trigger	general	Nov 12, 2024 2:48 PM	2a1fa2c2
crunchbase profile	general
li profile	general	Nov 12, 2024 2:48 PM	51baf8fe
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 2:48 PM	aca13c4d
news basic	general	Nov 12, 2024 2:48 PM	9947221b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

VERS

COM:VERSEON

Verseon